Statement by the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases about the study drug donanemab

Media contact: Will Sansom, 210-567-2579, sansom@uthscsa.edu SAN ANTONIO (May 22, 2023) — Alicia S. Parker, MD, of The University of Texas Health Science Center at San Antonio, is assistant professor of cognitive and behavioral neurology and clinic director for the health science center’s Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases. The Biggs Institute, in […]